Aphios Pharma
Growth Stage
Inspired by Nature, Enabled by Science
Overview
Raised: $48,152
Total Commitments ($USD)
Platform
Netcapital
Start Date
09/07/2018
Close Date
01/31/2019
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$99
Security Type
Equity - Common
SEC Filing Type
RegCF
Price Per Share
$1.00
Pre-Money Valuation
$101,070,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
02/03/2019
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$330
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2018
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Location
Woburn, Massachusetts
Aphios Pharma LLC is exploring how to best leverage, develop, and commercialize cannabis-based drugs for Central Nervous System (CNS) and other disorders. To accomplish this, Aphios Pharma “...utilizes supercritical fluid technologies to improve drug discovery, manufacturing, and formulation in a sustainable, environmentally-friendly manner.” They manufacture pharmaceutical-grade pure natural cannabinoids that both follow cGMP guidelines of the FDA and are in compliance with the Drug Enforcement Agency (DEA). So far, their work has led to endeavors that are likely to advance the science of cannabinoid-based medicines -- as well as make significant contributions to science and medicine.
Create a free account today to gain access to KingsCrowd analytics.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.